Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 4

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 4Colonoscopy 1Colonic Neoplasms 1

Interventions

Bevacizumab 187Fluorouracil 150Leucovorin 135Cetuximab 127Irinotecan 114Oxaliplatin 108pembrolizumab 96Capecitabine 82IFL protocol 53Panitumumab 43Nivolumab 43regorafenib 42Folfox protocol 39Gemcitabine 30trifluridine tipiracil drug combination 27Cisplatin 24Carboplatin 24atezolizumab 23Pemetrexed 20Paclitaxel 20Drug Therapy 20130-nm albumin-bound paclitaxel 17Trastuzumab 14encorafenib 13Trifluridine 13Ipilimumab 13HMPL-013 13tislelizumab 12spartalizumab 11Docetaxel 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Colorectal Neoplasms × MoviPrep × Clear all
NCT06597903 2024-09-19

A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution

Norgine

Phase 2 Completed
36 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02273167 2018-05-15

MORA

Norgine

Phase 3 Completed
849 enrolled 14 charts
Gastrointestinal

Colorectal Neoplasms

NCT01689792 2015-03-31

A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREPĀ®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)

Norgine

Phase 4 Completed
398 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01834742 2013-04-18

OUT

Norgine

Phase 1 Completed
161 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔